The observation that L-NAME, a non-selective NOS inhibitor, significantly enhanced GER's anticonvulsant effect suggests that inhibition of excessive NO production may be a key mechanism through which GER exerts its protective actions. Here, NOS1 is linked to gastroesophageal reflux disease.